EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Molecular Therapy Oncology

ISSN 2950-3299 · Elsevier BV

Latest articles

  1. Overcoming translational and manufacturing barriers of CAR-T cell therapy in the Brazilian landscape

    Cleyson da Cruz Oliveira Barros, Larissa Cardoso Zanetti, Lays Adrianne M. Trajano-Silva, Julia Carnaz Benincasa, Erica Kássia Sousa Vidal, Ingrid Ferreira de Souza, Robledo Aires Ferreira, Lilian de Oliveira Coser, Leonardo Javier Arcuri, Jamile Ramos da Silva, Yasmin Amirato, Rodrigo Coelho Ventura Pinto, Augusto Barbosa Junior, Juliana Aparecida Preto de Godoy, Raquel de Melo Alves Paiva, Oswaldo Keith Okamoto, Nelson Hamerschlak, Lucila Nassif Kerbauy

    Published: 2026-12DOI: 10.1016/j.omton.2026.201363

  2. Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC

    Gabriella Antignani, Michaela Feodoroff, Jacopo Chiaro, Sara Feola, Salvatore Russo, Firas Hamdan Hissaoui, Manlio Fusciello, Federica D’Alessio, Paolo Bottega, Yvonne Giannoula, Milda Sakalauskaite, Janita Sandberg, Miska Kosonen, Virpi Stigzelius, Tamara J. Luck, Valentina Ferrari, Daniele Ciampi, Markus Haapala, Rui Mamede Branca, Jukka Partanen, Satu Koskela, Maria Rescigno, Tiina Sikanen, Janne Lehtiö, Joseph Ndika, Otto K. Kari, Vilja M. Pietiäinen, Mikaela Grönholm, Vincenzo Cerullo

    Published: 2026-09DOI: 10.1016/j.omton.2026.201247

  3. Atorvastatin pre-exposure in hypercholesterolemia remedies 27HC mediated dendritic cell dysfunctions in triple-negative breast cancer

    Pritha Roy Choudhury, Mohona Chakravarti, Saurav Bera, Pooja Arora, Jasmine Sultana, Muqtada Ali Khan, Rushikesh Biradar, Aishwarya Guha, Sukanya Dhar, Indranil Ghosh, Nilanjan Ganguly, Aarti Lasure, Priyanka Kashyap, Juhina Das, Biswajit Mandal, Prodipto Das, Anirban Sarkar, Dipak Datta, Sukhendu Nandi, Neyaz Alam, Rathindranath Baral, Saptak Banerjee, Anamika Bose

    Published: 2026-09DOI: 10.1016/j.omton.2026.201250

Volumes

2026 · 2642025 · 1642024 · 141

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.